Showing 4,661 - 4,680 results of 18,420 for search 'significant ((((gap decrease) OR (((we decrease) OR (a decrease))))) OR (mean decrease))', query time: 0.58s Refine Results
  1. 4661

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
  2. 4662
  3. 4663
  4. 4664

    Heterogeneity analysis. by Ying Zhao (16546)

    Published 2025
    “…Instrumental variables (IVs) were identified as genome-wide significant single-nucleotide polymorphisms (SNPs) with a significance threshold of <i>P </i>< 1 × 10<sup>−8</sup> and an independence criterion of <i>r</i><sup>2</sup> < 0.001. …”
  5. 4665

    Reverse MR analysis data. by Ying Zhao (16546)

    Published 2025
    “…Instrumental variables (IVs) were identified as genome-wide significant single-nucleotide polymorphisms (SNPs) with a significance threshold of <i>P </i>< 1 × 10<sup>−8</sup> and an independence criterion of <i>r</i><sup>2</sup> < 0.001. …”
  6. 4666

    SNP dressing by screening. by Ying Zhao (16546)

    Published 2025
    “…Instrumental variables (IVs) were identified as genome-wide significant single-nucleotide polymorphisms (SNPs) with a significance threshold of <i>P </i>< 1 × 10<sup>−8</sup> and an independence criterion of <i>r</i><sup>2</sup> < 0.001. …”
  7. 4667
  8. 4668
  9. 4669
  10. 4670
  11. 4671

    Effect of O-ag modifying glycosyltransferases on complement activation and <i>Salmonella</i> interactions with human serum. by Fermin E. Guerra (6084545)

    Published 2025
    “…</i> Paratyphi A decrease complement activation as measured by C5a release and (B) IgM binding. …”
  12. 4672

    Reduction of L O-ag production and antigenic shift to O2-antigen in by Fermin E. Guerra (6084545)

    Published 2025
    “…<p><b><i>S.</i> Paratyphi A decreases IgM binding. (</b>A) and (B) Restored <i>S.…”
  13. 4673

    Continuing evolution of H5N1 highly pathogenic avian influenza viruses of clade 2.3.2.1a G2 genotype in domestic poultry of Bangladesh during 2018–2021 by Mohammed Nooruzzaman (3175290)

    Published 2024
    “…Consequently, antigenic analysis revealed a significant loss of cross-reactivity between viruses from different host species and periods. …”
  14. 4674
  15. 4675

    Validation of model predictions of growth during infusion of hypertrophic agonists with and without receptor blockers. by Johane H. Bracamonte (12883844)

    Published 2025
    “…By contrast, the model prediction of nearly equal likelihood that ERA increases or decreases NE-induced growth appears to contradict a significant reported decrease in the only available experimental study [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1012390#pcbi.1012390.ref121" target="_blank">121</a>]. …”
  16. 4676
  17. 4677
  18. 4678
  19. 4679
  20. 4680